Rhythm Pharmaceuticals (RYTM) had the highest return between June 5, 2022 and December 5, 2022 by a mid-cap US stock, returning 633.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rhythm Pharmaceuticals (RYTM) | 6/5/2022 - 12/5/2022 | 633.51% |
Akero Therapeutics (AKRO) | 6/5/2022 - 12/5/2022 | 410.67% |
Nuvalent (NUVL) | 6/5/2022 - 12/5/2022 | 269.7% |
Immunovant (IMVT) | 6/5/2022 - 12/5/2022 | 219.11% |
Axsome Therapeutics (AXSM) | 6/5/2022 - 12/5/2022 | 194.66% |
Verona Pharma PLC ADR (VRNA) | 6/5/2022 - 12/5/2022 | 178.07% |
Torm PLC Class A (TRMD) | 6/5/2022 - 12/5/2022 | 133.39% |
Impinj (PI) | 6/5/2022 - 12/5/2022 | 131.96% |
Catalyst Pharmaceuticals (CPRX) | 6/5/2022 - 12/5/2022 | 129.15% |
Belite Bio Inc ADR (BLTE) | 6/5/2022 - 12/5/2022 | 117.81% |
TransMedics (TMDX) | 6/5/2022 - 12/5/2022 | 115.75% |
Miniso Group Holding (MNSO) | 6/5/2022 - 12/5/2022 | 113.06% |
New Oriental Education & Technology (EDU) | 6/5/2022 - 12/5/2022 | 111.85% |
89bio (ETNB) | 6/5/2022 - 12/5/2022 | 109.55% |
ELF Beauty (ELF) | 6/5/2022 - 12/5/2022 | 103.2% |
Wingstop (WING) | 6/5/2022 - 12/5/2022 | 100.59% |
Vaxcyte (PCVX) | 6/5/2022 - 12/5/2022 | 99.77% |
Extreme Networks (EXTR) | 6/5/2022 - 12/5/2022 | 98.51% |
Kiniksa Pharmaceuticals (KNSA) | 6/5/2022 - 12/5/2022 | 93.72% |
F&G Annuities & Life (FG) | 6/5/2022 - 12/5/2022 | 93.1% |
TG Therapeutics (TGTX) | 6/5/2022 - 12/5/2022 | 87.16% |
Calix (CALX) | 6/5/2022 - 12/5/2022 | 85.77% |
Kymera Therapeutics (KYMR) | 6/5/2022 - 12/5/2022 | 84.71% |
Manchester United (MANU) | 6/5/2022 - 12/5/2022 | 82.38% |
International Seaways (INSW) | 6/5/2022 - 12/5/2022 | 74.96% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
